CSIMarket



Dyne Therapeutics Inc   (DYN)
Other Ticker:  
 
 

DYN's Free Cash Flow Growth by Quarter and Year

Dyne Therapeutics Inc 's Free Cash Flow results by quarter and year




DYN Free Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -28.07 -20.04 81.00
III Quarter September - -26.95 -611.47 149.00
II Quarter June - -46.15 84.00 27.00
I Quarter March -50.74 -18.39 271.00 297.00
FY   -50.74 -119.56 -276.51 554.00



DYN Free Cash Flow first quarter 2022 Y/Y Growth Comment
Dyne Therapeutics Inc in the first quarter 2022 recorded free cash outflow of $ -50.74 millions.

According to the results reported in the first quarter 2022, Dyne Therapeutics Inc achieved the best Free Cash Flow growth in Biotechnology & Pharmaceuticals industry. While Dyne Therapeutics Inc ' s Free Cash Flow no change of % ranks overall at the positon no. in the first quarter 2022.




DYN Free Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -21.99 %
II Quarter June - - 211.11 % -88.66 %
I Quarter March - - -8.75 % 126.72 %
FY   - - - 39.55 %

Financial Statements
Dyne Therapeutics Inc 's first quarter 2022 Free Cash Flow $ -50.74 millions DYN's Income Statement
Dyne Therapeutics Inc 's first quarter 2021 Free Cash Flow $ -18.39 millions Quarterly DYN's Income Statement
New: More DYN's historic Free Cash Flow Growth >>


DYN Free Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -45.64 %
III Quarter September - - - 451.85 %
II Quarter June - - -69 % -90.91 %
I Quarter March - - 234.57 % -
FY (Year on Year)   - - - 39.55 %




Free Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Dyne Therapeutics Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


DYN's I. Quarter Q/Q Free Cash Flow Comment
Current results of -50.74 millions by Dyne Therapeutics Inc look even more unfavourable compare to the -28.07 millions in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Dyne Therapeutics Inc achieved highest sequential Free Cash Flow growth. While Dyne Therapeutics Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


DYN's I. Quarter Q/Q Free Cash Flow Comment
Current free cash outflow of -50.74 millions by Dyne Therapeutics Inc appear even worse if you take a look at -28.07 millions free cash outflow in the forth quarter.

Within Biotechnology & Pharmaceuticals industry Dyne Therapeutics Inc achieved highest sequential Free Cash Flow growth. While Dyne Therapeutics Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Dyne Therapeutics Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Free Cash Flow 12 Months Ending $ -146.90 $ -115.95 $ -109.18 $ -918.14 $ -564.73
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment


Dyne Therapeutics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment


Dyne Therapeutics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
DYN's Free Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for DYN's Competitors
Free Cash Flow Growth for Dyne Therapeutics Inc 's Suppliers
Free Cash Flow Growth for DYN's Customers

You may also want to know
DYN's Annual Growth Rates DYN's Profitability Ratios DYN's Asset Turnover Ratio DYN's Dividend Growth
DYN's Roe DYN's Valuation Ratios DYN's Financial Strength Ratios DYN's Dividend Payout Ratio
DYN's Roa DYN's Inventory Turnover Ratio DYN's Growth Rates DYN's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Mar 31 2022
Adapthealth Corp 261.54%$ 261.540 millions
United Therapeutics Corporation221.49%$ 221.492 millions
Regeneron Pharmaceuticals Inc 214.39%$ 214.390 millions
Owens and Minor Inc 213.49%$ 213.492 millions
Merck and Co Inc 165.83%$ 165.829 millions
Dexcom Inc 155.40%$ 155.396 millions
Pacira Biosciences inc 154.76%$ 154.755 millions
Repligen Corp149.55%$ 149.547 millions
Apollo Medical Holdings Inc 141.54%$ 141.539 millions
Glaukos Corp133.94%$ 133.940 millions
Harmony Biosciences Holdings inc 130.26%$ 130.263 millions
Amphastar Pharmaceuticals Inc 122.41%$ 122.410 millions
Catalyst Pharmaceuticals Inc 122.29%$ 122.286 millions
Reynolds Consumer Products Inc 111.11%$ 111.111 millions
Davita Inc 108.81%$ 108.805 millions
Hologic Inc92.36%$ 92.358 millions
Eventbrite Inc 89.75%$ 89.746 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EAR's Profile

Stock Price

EAR's Financials

Business Description

Fundamentals

Charts & Quotes

EAR's News

Suppliers

EAR's Competitors

Customers & Markets

Economic Indicators

EAR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071